News

The phase 3 trial of once-daily roflumilast foam has shown promising results in the treatment of seborrheic dermatitis.

A poster session at Maui Derm NP+PA Fall delves into data surrounding the use of olive oil in therapeutic applications.

Mature minor statutes exist in most jurisdictions, but courts struggle with balancing the wishes of the adolescent with the need to show they fit into one of the exceptions to the general rule.

He delves into one of his most challenging recent cases, the evolution of treatment options, and strategies to think outside of the box in diagnostic and therapeutic approaches.

She shares her top 5 considerations for all dermatology drug prescribers.

Discover the data-driven pearls that will be presented in the main program at Maui Derm NP+PA Fall 2023.

Autumn is beautiful in Asheville, North Carolina, and you will find plenty to do between Maui Derm sessions.

Experts explain tactics that should be employed during the “retirement red zone” to allow for a financially successful retirement.

Connect with us in-person and discover innovative practice pearls throughout the weekend.

This week’s collection of the latest dermatologic studies covers chronic pruritus of unknown origin, vaccinating dermatology providers for HPV, body dysmorphic disorder among Lebanese women, and a case report of a pleomorphic dermal sarcoma with metastasis to the lung.

Sachin Shridharani, MD, discusses the results of a recent Allergan Aesthetics study exploring the efficacy of onabotulinumtoxinA in treating platysma prominence.

Ruth Ann Vleugels, MD, and Christopher Bunick, MD, agreed that the long-term safety data for JAK inhibitors makes them preferable to systemic steroids.

Abeona Therapeutics is seeking Priority Review and approval of the therapy for patients with recessive dystrophic epidermolysis bullosa.

A single-arm, prospective trial found that botulinum toxin injections did not have a significant effect on symptoms one month after treatment.

Researchers explored the relationship between psoriasis severity and its link to coronary microvascular dysfunction in the largest such study to date.

When combining adalimumab with surgery, patient outcomes, including quality of life, were improved.

Zoe Diana Draelos, MD, developed the study to examine the efficacy and tolerability of a once-daily 3% salicylic acid treatment gel containing turmeric, a low concentration of salicylic acid, and shea butter exfoliating moisturizer in the management of psoriasis flare-ups, either as a monotherapy or as a supplement to other psoriasis treatment regimens.

In this week’s Pointers With Portela, the 208SkinDoc reviews fungal acne and his recommended treatment strategy.

A patient’s journey toward weight loss for overall better health involves multifaceted considerations that extend beyond the numbers on a scale when it comes to sagging or excess skin.

Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.

Keep up with the latest headlines in dermatology from the past week, including efforts to raise awareness about the importance of skin checks and sun protection, CeraVe's role in expanding a dermatology residency training program, and more.

ICYMI, this week we had articles about periorbital rejuvenation, treating all skin tones, improving basal cell carcinoma management, and more.

Eligible candidates should apply by October 15, 2023, and one candidate will match in March 2024.

Efficacy of 1% colloidal oatmeal cream was similar to prescription barrier cream in treating mild to moderate atopic dermatitis.

A systematic review found that generally, combination therapy has evidence supportive of its efficacy in hidradenitis suppurativa.

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.

Today is National Native American Day. Dermatology Times is reviewing the unique dermatologic concerns and disparities faced by members of the Native and Indigenous communities.

Research has shown that biosimilars are highly similar to their originator product in terms of safety and efficacy.

Full clearance of recalcitrant warts was achieved in 68.6% of patients.